000 01494 a2200457 4500
005 20250515064420.0
264 0 _c20070613
008 200706s 0 0 eng d
022 _a0176-3679
024 7 _a10.1055/s-2007-972573
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGerlach, M
245 0 0 _aTherapeutic drug monitoring of quetiapine in adolescents with psychotic disorders.
_h[electronic resource]
260 _bPharmacopsychiatry
_cMar 2007
300 _a72-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aDibenzothiazepines
_xadverse effects
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Monitoring
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPilot Projects
650 0 4 _aProspective Studies
650 0 4 _aPsychotic Disorders
_xdrug therapy
650 0 4 _aQuetiapine Fumarate
650 0 4 _aSchizophrenia
_xdrug therapy
700 1 _aHünnerkopf, R
700 1 _aRothenhöfer, S
700 1 _aLibal, G
700 1 _aBurger, R
700 1 _aClement, H-W
700 1 _aFegert, J M
700 1 _aWewetzer, Ch
700 1 _aMehler-Wex, C
773 0 _tPharmacopsychiatry
_gvol. 40
_gno. 2
_gp. 72-6
856 4 0 _uhttps://doi.org/10.1055/s-2007-972573
_zAvailable from publisher's website
999 _c16996974
_d16996974